Citation: | LEI Xinyi, SONG Danjun, DAI Gaiguo, ZHANG Yunli, YANG Litao. Analysis of FN1, COL4A1, COL4A2 genes expression and significance in gastric cancer based on database mining[J]. Chinese Journal of General Practice, 2023, 21(11): 1967-1971. doi: 10.16766/j.cnki.issn.1674-4152.003269 |
[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[2] |
NIE Y, LIU L, LIU Q, et al. Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma[J]. Peer J, 2021, 9: e10908. DOI: 10.7717/peerj.10908.
|
[3] |
HUANG R, GU W, SUN B, et al. Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis[J]. Mol Med Rep, 2018, 17(5): 6387-6396.
|
[4] |
WANG M, LI Z, PENG Y, et al. Identification of immune cells and mRNA associated with prognosis of gastric cancer[J]. BMC Cancer, 2020, 20(1): 206. doi: 10.1186/s12885-020-6702-1
|
[5] |
PARK J H, PARK J, CHOI J K, et al. Identification of DNA methylation changes associated with human gastric cancer[J]. BMC Med Genomics, 2011, 4: 82. DOI: 10.1186/1755-8794-4-82.
|
[6] |
LI L, ZHU Z, ZHAO Y, et al. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics[J]. Sci Rep, 2019, 9(1): 7827. doi: 10.1038/s41598-019-43924-x
|
[7] |
ZHANG H, SUN Z, LI Y, et al. MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells[J]. Biomed Pharmacother, 2017, 88: 285-292. DOI: 10.1016/j.biopha.2017.01.023.
|
[8] |
ZHAO Q, XIE J, XIE J, et al. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer[J]. Cancer Biomark, 2021, 31(1): 59-75. doi: 10.3233/CBM-200594
|
[9] |
NIETO H R, THORNTON C E M, BROOKES K, et al. Recurrence of papillary thyroid cancer: a systematic appraisal of risk factors[J]. J Clin Endocrinol Metab, 2022, 107(5): 1392-1406. doi: 10.1210/clinem/dgab836
|
[10] |
WU J, WANG Y, XU X, et al. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer[J]. Carcinogenesis, 2016, 37(5): 511-521. doi: 10.1093/carcin/bgw029
|
[11] |
YANG X, HU Q, HU L X, et al. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1[J]. Discov Med, 2017, 24(131): 75-85.
|
[12] |
WANG S, GAO B, YANG H, et al. MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion[J]. Oncol Lett, 2019, 18(2): 1475-1482.
|
[13] |
DOU L, ZHANG X. Upregulation of CCT3 promotes cervical cancer progression through FN1[J]. Mol Med Rep, 2021, 24(6): 856. doi: 10.3892/mmr.2021.12496
|
[14] |
和华, 刘少朋, 刘海潮, 等. SPARCL1表达下调对胆囊癌吉西他滨耐药的作用机制及临床意义[J]. 中华全科医学, 2022, 20(10): 1666-1671. doi: 10.16766/j.cnki.issn.1674-4152.002674
HE H, LIU S P, LIU H C, et al. The mechanism and clinical significance of SPARCL1 down-regulation expression on gemcitabine resistance in gallbladder cancer[J]. Chin J Gen Pract, 2022, 20(10): 1666-1671. doi: 10.16766/j.cnki.issn.1674-4152.002674
|
[15] |
GUEY S, HERVE D. Main features of COL4A1-COL4A2 related cerebral microangiopathies[J]. Cereb Circ Cogn Behav, 2022, 3: 100140. DOI: 10.1016/j.cccb.2022.100140.
|
[16] |
JIN R, SHEN J, ZHANG T, et al. The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas[J]. Oncotarget, 2017, 8(35): 58172-58183. doi: 10.18632/oncotarget.17345
|
[17] |
CUI X, SHAN T, QIAO L. Collagen type Ⅳ Alpha 1(COL4A1) silence hampers the invasion, migration and epithelial-mesenchymal transition (EMT) of gastric cancer cells through blocking Hedgehog signaling pathway[J]. Bioengineered, 2022, 13(4): 8972-8981. doi: 10.1080/21655979.2022.2053799
|
[18] |
姚奇, 何兰珍. 基于数据库挖掘分析COL4A1基因在结直肠癌中的表达及意义[J]. 岭南现代临床外科, 2020, 20(2): 167-171. doi: 10.3969/j.issn.1009-976X.2020.02.007
YAO Q, HE L Z. Analysis of COL4A1 gene expression and significance in colorectal cancer based on database mining[J]. Lingnan Modern Clinics in Surgery, 2020, 20(2): 167-171. doi: 10.3969/j.issn.1009-976X.2020.02.007
|
[19] |
WANG S M, CHEN P M, SUNG Y W, et al. Effect of COL4A1 expression on the survival of neoadjuvant chemotherapy breast cancer patients[J]. J Oncol, 2020, 2020: 5209695. DOI: 10.1155/2020/5209695.
|
[20] |
WANG H, LIU Z, LI A, et al. COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma[J]. Exp Ther Med, 2021, 22(5): 1224. doi: 10.3892/etm.2021.10658
|
[21] |
FENG Z, QIAO R, REN Z, et al. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia? A microarray analysis based on regional population[J]. J Gastrointest Oncol, 2020, 11(2): 386-401. doi: 10.21037/jgo.2020.03.01
|
[22] |
JINGSONG H, HONG G, YANG J, et al. siRNA-mediated suppression of collagen type iv alpha 2 (COL4A2) mRNA inhibits triple-negative breast cancer cell proliferation and migration[J]. Oncotarget, 2017, 8(2): 2585-2593. doi: 10.18632/oncotarget.13716
|